Cannabis Laws in Australia

ACT decriminalization, TGA medical program, and navigating the complex patchwork of state and territory cannabis penalties across the Land Down Under.

Key Findings: Australia Cannabis Status 2024

Federal Status Illegal
ACT Territory Decriminalized 50g / 2 plants
Medical Cannabis Legal TGA regulated
Medical Patients 100,000+ approved (2024)
Driving Limit Zero THC All states
Tourist Access No Legal Retail

Legal Status at a Glance

Australia presents one of the most complex cannabis legal landscapes in the world. Each state and territory maintains different approaches, ranging from Queensland's strict criminal penalties to the ACT's progressive decriminalization model. Understanding these distinctions is critical for both residents and visitors.

Category Status Details
Recreational Use Illegal Federal prohibition under Criminal Code Act 1995; ACT decriminalized for personal use only
Medical Cannabis Legal TGA Special Access Scheme and Authorised Prescriber pathway since November 2016
Public Possession Varies by State ACT: 50g legal. SA: AUD 500 fine up to 100g. NSW/VIC: Caution system. QLD: Criminal offence
Home Cultivation ACT Only 2 plants per person, maximum 4 per household in ACT; criminal offence elsewhere
Retail Access None No legal recreational sales anywhere in Australia; medical via pharmacies only
Driving Limit Zero THC Oral fluid testing in all states; any detectable THC is an offence including for medical patients
Tourist Access High Risk No legal purchase options; ACT decriminalization covers possession but not supply

Current Legal Framework

At the federal level, cannabis remains a prohibited substance under the Criminal Code Act 1995 (Cth) and the Narcotic Drugs Act 1967 (Cth). These laws classify cannabis as a Schedule 9 prohibited substance under the Standard for the Uniform Scheduling of Medicines and Poisons (SUSMP). However, Australia's constitutional framework grants states and territories significant autonomy in drug enforcement, resulting in the current patchwork system.

The Australian Capital Territory made history on 31 January 2020 when the Drugs of Dependence (Personal Cannabis Use) Amendment Act 2019 came into effect. This landmark legislation, championed by Labor MLA Michael Pettersson, decriminalized personal cannabis possession for adults aged 18 and over. Under ACT law, individuals may possess up to 50 grams of dried cannabis and cultivate up to 2 plants per person (maximum 4 per household). Importantly, the law specifies that cannabis must be stored out of reach of children, and artificial cultivation methods (hydroponics) remain prohibited.

South Australia was actually the first Australian jurisdiction to implement cannabis decriminalization, introducing its Cannabis Expiation Notice (CEN) scheme in 1987 under the Controlled Substances Act 1984 (SA). This system allows police to issue on-the-spot fines rather than criminal charges for minor cannabis offences. Possession of up to 100 grams of cannabis incurs an AUD 500 expiation fee, while cultivating a single plant attracts an AUD 150 fine. Notably, failure to pay the expiation fee within 60 days results in criminal prosecution.

The Narcotic Drugs Amendment Act 2016 (Cth) established the legal framework for Australia's medical cannabis scheme, which commenced on 30 November 2016. The Office of Drug Control (ODC), part of the Therapeutic Goods Administration (TGA), oversees the licensing of cannabis cultivation, production, and manufacture for medicinal purposes. Patients access medical cannabis through the Special Access Scheme Category B (SAS-B) or via an Authorised Prescriber. As of 2024, the TGA has approved over 100,000 patients for medical cannabis, with chronic pain, anxiety, and epilepsy being the most common qualifying conditions.

Penalties and Enforcement

Offense Quantity Penalty Enforcement Reality
ACT Possession Up to 50g No penalty (decriminalized) Minimal enforcement; few formal cautions issued since 2020
SA Possession Up to 100g AUD 500 expiation fee Consistently applied; over 8,000 CENs issued annually
NSW Possession Up to 15g Cannabis caution (max 2) Police discretion; third offence becomes criminal
Victoria Possession Up to 50g Cannabis caution (max 3) Drug diversion program emphasis; fourth offence criminal
QLD Possession Any amount Up to 15 years imprisonment Strictly enforced; criminal record for any possession
WA Possession Up to 10g AUD 200 infringement notice Cannabis Intervention Requirement (CIR) may apply
Trafficking (Federal) Commercial quantity 10-25 years imprisonment AFP actively prosecutes; organized crime focus
Drug Driving Any detectable THC AUD 500-2,000 fine + license loss Heavy enforcement; roadside MDT testing common

Medical Cannabis Program

Australia's medical cannabis program has experienced remarkable growth since its establishment in November 2016. The Therapeutic Goods Administration (TGA) oversees the scheme through two primary access pathways: the Special Access Scheme Category B (SAS-B) and the Authorised Prescriber (AP) pathway. As of 2024, the Office of Drug Control (ODC) reports over 100,000 patients have been approved for medical cannabis treatment.

To access medical cannabis, patients must first consult with a registered medical practitioner. The prescribing doctor must apply to the TGA for SAS-B approval, which is typically granted within 48 hours for straightforward cases. Alternatively, doctors can become Authorised Prescribers, allowing them to prescribe to multiple patients without individual TGA approval. The most common qualifying conditions include chronic non-cancer pain (approximately 65% of approvals), anxiety disorders (15%), cancer-related symptoms (8%), epilepsy (5%), and multiple sclerosis (3%).

The range of available products has expanded significantly. As of 2024, the TGA has listed over 400 medical cannabis products, including cannabis oils, oral capsules, dried flower for vaporization, and topical preparations. CBD-only products (Schedule 4) require a standard prescription, while THC-containing products (Schedule 8) require SAS-B approval or an Authorised Prescriber. Monthly costs for medical cannabis typically range from AUD 200 to AUD 600, depending on the product and dosage.

A significant limitation of Australia's medical cannabis program is the conflict with drug driving laws. All states and territories enforce zero-tolerance THC driving limits, meaning medical cannabis patients can be charged with drug driving even when not impaired. In Victoria, the Medicinal Cannabis and Safe Driving Working Group recommended reforms in 2023, but no legislative changes have been implemented. Patients must wait until THC is undetectable in oral fluid (typically 6-12 hours minimum) before driving, creating practical challenges for those using THC-containing medications.

Industry and Market Data

Australia's medical cannabis industry has evolved into a significant economic sector, with an estimated annual market value of AUD 350 million in 2024. The domestic market is served by over 100 ODC-licensed cultivators, manufacturers, and producers, ranging from large pharmaceutical companies to boutique craft producers. Major players include Cannatrek, Little Green Pharma, Althea Group, and Cann Group, all of which are ASX-listed companies.

Australia has also emerged as a significant exporter of medical cannabis, leveraging its reputation for pharmaceutical-grade production and favorable growing conditions. Key export destinations include the United Kingdom, Germany, and Israel. Little Green Pharma became the first Australian company to export medical cannabis to the UK in 2020, while Cannatrek has established supply agreements with distributors across Europe. Export revenue reached approximately AUD 50 million in 2023.

The patient population has grown exponentially since the program's inception. From just 500 approvals in 2017, the TGA recorded over 100,000 cumulative patient approvals by mid-2024. Monthly approval rates now exceed 5,000 new patients. This growth has been driven by increased doctor awareness, telehealth consultations (particularly during the COVID-19 pandemic), and the establishment of dedicated medical cannabis clinics in major cities.

In the ACT, where decriminalization has been in effect since January 2020, enforcement data reveals minimal intervention. ACT Policing has issued fewer than 50 formal cannabis cautions since the law's implementation, suggesting that the policy has effectively removed cannabis possession from the criminal justice system in the territory. However, the lack of legal supply means that all cannabis in the ACT originates from either home cultivation or the illicit market.

Cannabis Culture and History

Cannabis has a long history in Australia, with the first recorded cannabis cultivation dating to 1788 when hemp seeds were brought on the First Fleet. Throughout the 19th century, cannabis was legally available in pharmacies as a medicine. Recreational use emerged in the early 20th century, particularly among returned servicemen after World War I, leading to the first prohibitions in the 1920s and 1930s under state poisons legislation.

The counterculture movements of the 1960s and 1970s brought cannabis into mainstream Australian consciousness. The Nimbin Mardi Grass festival, established in 1973 in New South Wales, became an iconic annual celebration of cannabis culture and activism. Despite occurring in a state where cannabis remains illegal, the festival continues to attract thousands of attendees each May, featuring speakers, music, and the infamous "Nimbin Hemp Olympics." The event has been instrumental in shaping Australian cannabis reform discourse.

Contemporary cannabis culture in Australia reflects the nation's federal-state divide. In the ACT, cannabis social clubs have emerged since decriminalization, offering spaces for growers to share knowledge and techniques. The "Canberra Cannabis Community" Facebook group has over 15,000 members discussing everything from cultivation tips to legal developments. Meanwhile, in states like Queensland, cannabis users maintain a more underground culture, aware that even minor possession carries serious criminal risk. The ongoing disparity between jurisdictions has fueled calls for national cannabis reform, with polls consistently showing that over 60% of Australians support decriminalization of personal use.

Traveler Guide

Essential Information for Travelers

Australia offers no legal recreational cannabis purchase options. Even in the ACT where possession is decriminalized, supply remains a criminal offence. International travelers face heightened scrutiny at Australian borders, with Australian Border Force maintaining strict enforcement.

Understanding State Differences: Before traveling within Australia, research the specific laws of your destination state or territory. What is decriminalized in the ACT becomes a criminal offence the moment you cross into NSW. South Australia's expiation system differs significantly from Victoria's caution scheme. Queensland maintains the strictest approach, where any possession results in criminal charges.

Drug Driving Reality: Australia's zero-tolerance drug driving laws affect all travelers. Roadside Mobile Drug Testing (MDT) is conducted by police throughout all states and territories. The oral fluid test can detect THC for up to 12 hours after consumption, and sometimes longer for regular users. Unlike alcohol testing, there is no legal THC limit—any positive result is an offence. Penalties include immediate license suspension, fines up to AUD 2,000, and potential imprisonment for repeat offenders.

Border Security: Australian Border Force operates one of the world's strictest border control regimes. Attempting to import any cannabis product, including CBD oils legal in other countries, is a serious criminal offence under the Customs Act 1901 (Cth). Penalties include up to 25 years imprisonment for commercial quantities. Detector dogs and advanced scanning technology are deployed at all international airports and mail centers.

Medical Cannabis for Visitors: There is currently no established pathway for international visitors to legally access medical cannabis in Australia. The TGA requires patients to have a prescription from an Australian medical practitioner. Importing your own medical cannabis from overseas remains illegal, regardless of its legal status in your home country. The only exception is the TGA's Traveller's Exemption scheme, which allows Australian citizens returning from overseas to bring up to 3 months supply of medicine prescribed overseas—however, this rarely applies to cannabis products due to international scheduling.

Practical Dos and Don'ts:

Share: